Morgan Stanley Molecular Templates, Inc. Transaction History

Morgan Stanley

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.39 - $0.54 $11,310 - $15,660	-29,000 Reduced 27.0%	78,423 $37,000
Q1 2023 May 15, 2023	BUY	$0.33 - $0.58 $7,506 - $13,192	22,746 Added 26.86%	107,423 $40,000
Q4 2022 Feb 14, 2023	SELL	$0.33 - $12.0 $9,389 - $341,448	-28,454 Reduced 25.15%	84,677 $27,000
Q3 2022 Nov 14, 2022	SELL	$0.68 - $11.25 $28,914 - $478,361	-42,521 Reduced 27.32%	113,131 $85,000
Q2 2022 Oct 27, 2022	SELL	$0.81 - $3.43 $62,944 - $266,541	-77,709 Reduced 33.3%	155,652 $143,000
Q2 2022 Aug 15, 2022	SELL	$0.81 - $3.43 $62,944 - $266,541	-77,709 Reduced 33.3%	155,652 $143,000
Q1 2022 Oct 27, 2022	BUY	$2.27 - $4.13 $176,399 - $320,938	77,709 Added 49.92%	233,361 $805,000
Q1 2022 May 13, 2022	SELL	$2.27 - $4.13 $390,237 - $709,992	-171,911 Reduced 42.42%	233,361 $805,000
Q4 2021 Feb 14, 2022	SELL	$3.37 - $6.87 $5,354 - $10,916	-1,589 Reduced 0.39%	405,272 $1.59 Million
Q3 2021 Nov 15, 2021	BUY	$5.78 - $7.86 $2.35 Million - $3.2 Million	406,861 New	406,861 $2.73 Million

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $7.33M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.